Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages

Science Signaling

Volumn 9, Issue 443, 2016, Pages

  Piccinini, Anna M ^a,b   Zuliani Alvarez, Lorena ^a   Lim, Jenny M P ^a   Midwood, Kim S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; FIBRINOGEN; FIBRINOGEN LIKE GLOBE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PATTERN RECOGNITION RECEPTOR; PHOSPHOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TENASCIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE; TLR4 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MICROENVIRONMENT; PHENOTYPE; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; IMMUNOLOGY; METABOLISM; TUMOR MICROENVIRONMENT;

CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; TENASCIN; TOLL-LIKE RECEPTOR 4;

EID: 84988878462     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aaf3596     Document Type: Article

References (77)

1. T. A. Wynn, A. Chawla, J. W. Pollard, Macrophage biology in development, homeostasis and disease. Nature 496, 445-455 (2013).
2. D. M. Mosser, J. P. Edwards, Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
3. S. Epelman, K. J. Lavine, G. J. Randolph, Origin and functions of tissue macrophages. Immunity 41, 21-35 (2014).
4. Y. Lavin, D. Winter, R. Blecher-Gonen, E. David, H. Keren-Shaul, M. Merad, S. Jung, I. Amit, Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312-1326 (2014).
5. M. Haldar, M. Kohyama, A. Y.-L. So, W. KC, X. Wu, C. G. Briseño, A. T. Satpathy, N. M. Kretzer, H. Arase, N. S. Rajasekaran, L. Wang, T. Egawa, K. Igarashi, D. Baltimore, T. L. Murphy, K. M. Murphy, Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156, 1223-1234 (2014).
6. Y. Okabe, R. Medzhitov, Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157, 832-844 (2014).
7. S. Abutbul, J. Shapiro, I. Szaingurten-Solodkin, N. Levy, Y. Carmy, R. Baron, S. Jung, A. Monsonego, TGF-b signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia 60, 1160-1171 (2012).
8. P. R. Taylor, L. Martinez-Pomares, M. Stacey, H.-H. Lin, G. D. Brown, S. Gordon, Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901-944 (2005).
9. C. E. Bryant, N. J. Gay, S. Heymans, S. Sacre, L. Schaefer, K. S. Midwood, Advances in Toll-like receptor biology: Modes of activation by diverse stimuli. Crit. Rev. Biochem. Mol. Biol. 50, 359-379 (2015).
10. I. A. Udalova, M. Ruhmann, S. J. P. Thomson, K. S. Midwood, Expression and immune function of tenascin-C. Crit. Rev. Immunol. 31, 115-145 (2011).
11. K. Midwood, S. Sacre, A. M. Piccinini, J. Inglis, A. Trebaul, E. Chan, S. Drexler, N. Sofat, M. Kashiwagi, G. Orend, F. Brennan, B. Foxwell, Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780 (2009).
12. L. Patel, W. Sun, S. S. Glasson, E. A. Morris, C. R. Flannery, P. S. Chockalingam, Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet. Disord. 12, 164 (2011).
13. N. Kuriyama, S. Duarte, T. Hamada, R. W. Busuttil, A. J. Coito, Tenascin-C: A novel mediator of hepatic ischemia and reperfusion injury. Hepatology 54, 2125-2136 (2011).
14. P. J. Murray, J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, M. Locati, A. Mantovani, F. O. Martinez, J.-L. Mege, D. M. Mosser, G. Natoli, J. P. Saeij, J. L. Schultze, K. A. Shirey, A. Sica, J. Suttles, I. Udalova, J. A. van Ginderachter, S. N. Vogel, T. A. Wynn, Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41, 14-20 (2014).
15. K. S. Lilley, Protein profiling using two-dimensional difference gel electrophoresis (2-D DIGE). Curr. Protoc. Protein Sci. 22, 1-14 (2003).
16. G. Weintz, J. V. Olsen, K. Frühauf, M. Niedzielska, I. Amit, J. Jantsch, J. Mages, C. Frech, L. Dölken, M. Mann, R. Lang, The phosphoproteome of toll-like receptor-activated macrophages. Mol. Syst. Biol. 6, 371 (2010).
17. V. Sjoelund, M. Smelkinson, A. Nita-Lazar, Phosphoproteome profiling of the macrophage response to different toll-like receptor ligands identifies differences in global phosphorylation dynamics. J. Proteome Res. 13, 5185-5197 (2014).
18. J. M. Blander, Coupling Toll-like receptor signaling with phagocytosis: Potentiation of antigen presentation. Trends Immunol. 28, 19-25 (2007).
19. D. C. Morrison, L. F. Kline, Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J. Immunol. 118, 362-368 (1977).
20. L. Koch, S. Hofer, M. A. Weigand, D. Frommhold, J. Poeschl, P. Ruef, Inhibition of LPS-induced activation of coagulation by p38 MAPK inhibitor. ISRN Hematol. 2012, 762614 (2012).
21. K. A. Shirey, W. Lai, A. J. Scott, M. Lipsky, P. Mistry, L.M. Pletneva, C. L. Karp, J. McAlees, T. L. Gioannini, J. Weiss, W. H. Chen, R. K. Ernst, D. P. Rossignol, F. Gusovsky, J. C. G. Blanco, S. N. Vogel, The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 498-502 (2013).
22. Y. Goto, K. Ogawa, T. J. Nakamura, A. Hattori, M. Tsujimoto, TLR-mediated secretion of endoplasmic reticulum aminopeptidase 1 from macrophages. J. Immunol. 192, 4443-4452 (2014).
23. B. Calippe, V. Douin-Echinard, L. Delpy, M. Laffargue, K. Lélu, A. Krust, B. Pipy, F. Bayard, J.-F. Arnal, J.-C. Guery, P. Gourdy, 17b-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor a signaling in macrophages in vivo. J. Immunol. 185, 1169-1176 (2010).
24. P. N. Shashkin, G. T. Brown, A. Ghosh, G. K. Marathe, T. M. McIntyre, Lipopolysaccharide is a direct agonist for platelet RNA splicing. J. Immunol. 181, 3495-3502 (2008).
25. K. Yamazaki, K. Suzuki, E. Yamada, T. Yamada, F. Takeshita, M. Matsumoto, T. Mitsuhashi, T.Obara, K. Takano, K.Sato, Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles. Endocrinology 148, 3226-3235 (2007).
26. S. Galván-Peña, L. A. J. O'Neill, Metabolic reprograming in macrophage polarization. Front. Immunol. 5, 420 (2014).
27. M. Schaff, N. Receveur, C. Bourdon, V. Wurtz, C. V. Denis, G. Orend, C. Gachet, F. Lanza, P. H. Mangin, Novel function of tenascin-C, a matrix protein relevant to atherosclerosis, in platelet recruitment and activation under flow. Arterioscler. Thromb. Vasc. Biol. 31, 117-124 (2011).
28. K. S. Midwood, T. Hussenet, B. Langlois, G. Orend, Advances in tenascin-C biology. Cell. Mol. Life Sci. 68, 3175-3199 (2011).
29. M. A. Ghert, W. N. Qi, H. P. Erickson, J. A. Block, S. P. Scully, Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. Cell Struct. Funct. 26, 179-187 (2001).
30. R. A. Clark, H. P. Erickson, T. A. Springer, Tenascin supports lymphocyte rolling. J. Cell Biol. 137, 755-765 (1997).
31. X.-G. Gong, Y.-F. Lv, X.-Q. Li, F.-G. Xu, Q.-Y. Ma, Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. Biol. Pharm. Bull. 33, 1261-1267 (2010).
32. T. Sumioka, N. Fujita, A. Kitano, Y. Okada, S. Saika, Impaired angiogenic response in the cornea of mice lacking tenascin C. Invest.Ophthalmol. Vis. Sci. 52, 2462-2467 (2011).
33. Y. Urushizaki, S. Seifter, Phosphorylation of hydroxylysine residues in collagen synthesized by cultured aortic smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 82, 3091-3095 (1985).
34. E. P. Zimina, A. Fritsch, B. Schermer, A. Y. Bakulina, M. Bashkurov, T. Benzing, L. Bruckner-Tuderman, Extracellular phosphorylation of collagen XVII by ecto-casein kinase 2 inhibits ectodomain shedding. J. Biol. Chem. 282, 22737-22746 (2007).
35. D. Olsen, J. Jiang, R. Chang, R. Duffy, M. Sakaguchi, S. Leigh, R. Lundgard, J. Ju, F. Buschman, V. Truong-Le, B. Pham, J. W. Polarek, Expression and characterization of a low molecular weight recombinant human gelatin: Development of a substitute for animal-derived gelatin with superior features. Protein Expr. Purif. 40, 346-357 (2005).
36. K.Sharma, R.C. J.D'Souza, S. Tyanova, C. Schaab, J. R. Wisniewski, J. Cox, M. Mann, Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 8, 1583-1594 (2014).
37. S. A. Beausoleil, J. Villén, S. A. Gerber, J. Rush, S. P. Gygi, A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285-1292 (2006).
38. H. Molina, D. M. Horn, N. Tang, S. Mathivanan, A. Pandey, Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 104, 2199-2204 (2007).
39. E. Adiguzel, G. Hou, D. Mulholland, U. Hopfer, N. Fukai, B. Olsen, M. Bendeck, Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagennull alleles. Arterioscler. Thromb. Vasc. Biol. 26, 56-61 (2006).
40. J. Banyard, L. Bao, B. R. Zetter, Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J. Biol. Chem. 278, 20989-20994 (2003).
41. K. Misawa, T. Kanazawa, A. Imai, S. Endo, D. Mochizuki, H. Fukushima, Y. Misawa, H. Mineta, Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Mol. Clin. Oncol. 2, 285-291 (2014).
42. K. S. Midwood, G. Orend, The role of tenascin-C in tissue injury and tumorigenesis. J. Cell Commun. Signal. 3, 287-310 (2009).
43. D. M. Rothwarf, E. Zandi, G. Natoli, M. Karin, IKK-g is an essential regulatory subunit of the IkB kinase complex. Nature 395, 297-300 (1998).
44. P. Bartuzi, M. H. Hofker, B. van de Sluis, Tuning NF-kB activity: A touch of COMMD proteins. Biochim. Biophys. Acta 1832, 2315-2321 (2013).
45. B. Janji, A. Giganti, V. De Corte, M. Catillon, E. Bruyneel, D. Lentz, J. Plastino, J. Gettemans, E. Friederich, Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells. J. Cell Sci. 119, 1947-1960 (2006).
46. S. Mostowy, P. Cossart, Septins: The fourth component of the cytoskeleton. Nat. Rev. Mol. Cell Biol. 13, 183-194 (2012).
47. T. Katsumoto, A. Mitsushima, T. Kurimura, The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computergraphic reconstruction. Biol. Cell 68, 139-146 (1990).
48. K. Tanaka, N. Hiraiwa, H. Hashimoto, Y. Yamazaki, M. Kusakabe, Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int. J. Cancer 108, 31-40 (2004).
49. P. Bist, S. Shu, H. Lee, S. Arora, S. Nair, J. Y. Lim, J. Dayalan, S. Gasser, S. K. Biswas, A.-M. Fairhurst, L. H. K. Lim, Annexin-A1 regulates TLR-mediated IFN-b production through an interaction with TANK-binding kinase 1. J. Immunol. 191, 4375-4382 (2013).
50. J. F. A. Swisher, N. Burton, S. M. Bacot, S. N. Vogel, G. M. Feldman, Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 115, 549-558 (2010).
51. M. Chopin, C. A. Chacón-Martínez, R. Jessberger, Fine tuning of IRF-4 expression by SWAP-70 controls the initiation of plasma cell development. Eur. J. Immunol. 41, 3063-3074 (2011).
52. B. Kelly, L. A. J. O'Neill, Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771-784 (2015).
53. T. T. N. Nguyen, Y. M. Kim, T. D. Kim, O. T. T. Le, J. J. Kim, H. C. Kang, H. Hasegawa, Y. Kanaho, I. Jou, S. Y. Lee, Phosphatidylinositol 4-phosphate 5-kinase a facilitates Tolllike receptor 4-mediated microglial inflammation through regulation of the Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location. J. Biol. Chem. 288, 5645-5659 (2013).
54. O. T. Le, T. T. Nguyen, S. Y. Lee, Phosphoinositide turnover in Toll-like receptor signaling and trafficking. BMB Rep. 47, 361-368 (2014).
55. C.-Y. Chiang, V. Veckman, K. Limmer, M. David, Phospholipase Cg-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J. Biol. Chem. 287, 3704-3709 (2012).
56. S. Carpenter, E. P. Ricci, B. C. Mercier, M. J. Moore, K. A. Fitzgerald, Post-transcriptional regulation of gene expression in innate immunity. Nat. Rev. Immunol. 14, 361-376 (2014).
57. A. M. Piccinini, K. S. Midwood, DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 672395 (2010).
58. A. Veis, C. Sfeir, C. B. Wu, Phosphorylation of the proteins of the extracellular matrix of mineralized tissues by casein kinase-like activity. Crit. Rev. Oral Biol. Med. 8, 360-379 (1997).
59. D. Volpin, A. Veis, Cyanogen bromide peptides from insoluble skin and dentin bovine collagens. Biochemistry 12, 1452-1464 (1973).
60. T. Ishigaki, K. Imanaka-Yoshida, N. Shimojo, S. Matsushima, W. Taki, T. Yoshida, Tenascin-C enhances crosstalk signaling of integrin avb3/PDGFR-b complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J. Cell. Physiol. 226, 2617-2624 (2011).
61. V. Van De Bor, G. Zimniak, L. Papone, D. Cerezo, M. Malbouyres, T. Juan, F. Ruggiero, S. Noselli, Companion blood cells control ovarian stem cell niche microenvironment and homeostasis. Cell Rep. 13, 546-560 (2015).
62. J. Vaage, W. J. Lindblad, Production of collagen type I by mouse peritoneal macrophages. J. Leukoc. Biol. 48, 274-280 (1990).
63. B. Weitkamp, P. Cullen, G. Plenz, H. Robenek, J. Rauterberg, Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J. 13, 1445-1457 (1999).
64. M. Schnoor, P. Cullen, J. Lorkowski, K. Stolle, H. Robenek, D. Troyer, J. Rauterberg, S. Lorkowski, Production of type VI collagen by human macrophages: A new dimension in macrophage functional heterogeneity. J. Immunol. 180, 5707-5719 (2008).
65. B. Leitinger, E. Hohenester, Mammalian collagen receptors. Matrix Biol. 26, 146-155 (2007).
66. J. E. Scott, Extracellular matrix, supramolecular organisation and shape. J. Anat. 187 (Pt. 2), 259-269 (1995).
67. M. J. Rowley, K. S. Nandakumar, R. Holmdahl, The role of collagen antibodies in mediating arthritis. Mod. Rheumatol. 18, 429-441 (2008).
68. K. R. Taylor, K. Yamasaki, K. A. Radek, A. Di Nardo, H. Goodarzi, D. Golenbock, B. Beutler, R. L. Gallo, Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265-18275 (2007).
69. V. A. Lightner, C. A. Slemp, H. P. Erickson, Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma. Ann. N. Y. Acad. Sci. 580, 260-275 (1990).
70. J. B. Ventimiglia, C. J. Wikstrand, L. E. Ostrowski, M. A. Bourdon, V. A. Lightner, D. D. Bigner, Tenascin expression in human glioma cell lines and normal tissues. J. Neuroimmunol. 36, 41-55 (1992).
71. S. Ruggiero, R. Cosgarea, J. Potempa, B. Potempa, S. Eick, M. Chiquet, Cleavage of extracellular matrix in periodontitis: Gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C. Biochim. Biophys. Acta 1832, 517-526 (2013).
72. F. G. Goh, A. M. Piccinini, T. Krausgruber, I. A. Udalova, K. S. Midwood, Transcriptional regulation of the endogenous danger signal tenascin-C: A novel autocrine loop in inflammation. J. Immunol. 184, 2655-2662 (2010).
73. M. Machida, H. Kosako, K. Shirakabe, M. Kobayashi, M. Ushiyama, J. Inagawa, J. Hirano, T. Nakano, Y. Bando, E. Nishida, S. Hattori, Purification of phosphoproteins by immobilized metal affinity chromatography and its application to phosphoproteome analysis. FEBS J. 274, 1576-1587 (2007).
74. H. Mi, A. Muruganujan, J. T. Casagrande, P. D. Thomas, Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551-1566 (2013).
75. D. Szklarczyk, A. Franceschini, S. Wyder, K. Forslund, D. Heller, J. Huerta-Cepas, M. Simonovic, A. Roth, A. Santos, K. P. Tsafou, M. Kuhn, P. Bork, L. J. Jensen, C. von Mering, STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447-D452 (2015).
76. P. V. Hornbeck, B. Zhang, B. Murray, J. M. Kornhauser, V. Latham, E. Skrzypek, PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512-D520 (2015).
77. A. M. Woskowicz, S. A. Weaver, Y. Shitomi, N. Ito, Y. Itoh, MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion. J. Biol. Chem. 288, 35126-35137 (2013).